The Art of Validating Quantitative Proteomics Data

Western blotting as an orthogonal validation tool for quantitative proteomics data has rapidly become a de facto requirement for publication. In this viewpoint article, the pros and cons of western blotting as a validation approach are discussed, using examples from our own published work, and how to best apply it to improve the quality of data published is outlined. Further, suggestions and guidelines for some other experimental approaches are provided, which can be used for validation of quantitative proteomics data in addition to, or in place of, western blotting.

[1]  Emma Lundberg,et al.  A proposal for validation of antibodies , 2016, Nature Methods.

[2]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[3]  A. Fennell,et al.  Shotgun proteomic analysis of photoperiod regulated dormancy induction in grapevine. , 2018, Journal of proteomics.

[4]  Methods to Study Protein Tyrosine Phosphatases Acting on Yeast MAPKs. , 2016, Methods in molecular biology.

[5]  Modesto Orozco,et al.  SDS-PAGE analysis of Aβ oligomers is disserving research into Alzheimer´s disease: appealing for ESI-IM-MS , 2015, Scientific Reports.

[6]  V. Gupta,et al.  Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models , 2018, Molecular & Cellular Proteomics.

[7]  Sarah Jackson.  The importance of being transparent. , 2015, The Journal of clinical investigation.

[8]  Lennart Martens,et al.  Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 2.1. , 2016, Journal of proteome research.

[9]  Chih-Chiang Tsou,et al.  DIA-Umpire: comprehensive computational framework for data-independent acquisition proteomics , 2015, Nature Methods.

[10]  J. Chick,et al.  Quantitative proteomic analysis of two different rice varieties reveals that drought tolerance is correlated with reduced abundance of photosynthetic machinery and increased abundance of ClpD1 protease. , 2016, Journal of proteomics.

[11]  Lakshmi Narayana Yaddanapudi,et al.  The American Statistical Association statement on P-values explained , 2016, Journal of anaesthesiology, clinical pharmacology.

[12]  Xianzhong Meng,et al.  Activation of sirtuin 1/3 improves vascular hyporeactivity in severe hemorrhagic shock by alleviation of mitochondrial damage , 2015, Oncotarget.

[13]  Michael J MacCoss,et al.  Statistical control of peptide and protein error rates in large-scale targeted DIA analyses , 2017, Nature Methods.

[14]  Dana Pascovici,et al.  Multiple testing corrections in quantitative proteomics: A useful but blunt tool , 2016, Proteomics.

[15]  R. Aebersold,et al.  Western Blots versus Selected Reaction Monitoring Assays: Time to Turn the Tables? , 2013, Molecular & Cellular Proteomics.

[16]  D. Raftos,et al.  Potential protein biomarkers of QX disease resistance in selectively bred Sydney Rock Oysters , 2018, Aquaculture.

[17]  S. Gygi,et al.  Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes , 2017, Scientific Reports.

[18]  Regina Nuzzo,et al.  Scientific method: Statistical errors , 2014, Nature.

[19]  D. Raftos,et al.  Biomarkers of Winter Mortality resistance in selectively bred Sydney rock oysters (Saccostrea glomerata) , 2016 .

[20]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Lazar,et al.  The ASA Statement on p-Values: Context, Process, and Purpose , 2016 .